To Explore the Mechanism of Hawthorn in the Intervention of Hyperlipidemia Based on the Gene Expression Omnibus and Network Pharmacology

被引:0
|
作者
Song, Xuejing [1 ]
Li, Hong [1 ]
Liang, Y. [1 ]
Chen, J. [2 ]
Zhao, L. Z. [3 ]
Tang, C. [3 ]
机构
[1] Southwest Med Univ, Dept Pharmacol, Luzhou 646099, Sichuan, Peoples R China
[2] Luzhou Hosp Tradit Chinese Med, Dept Pharmacol, Luzhou, Peoples R China
[3] Southwest Med Univ, Dept Cardiol, Affiliated Tradit Chinese Med Hosp, Luzhou 646000, Sichuan, Peoples R China
关键词
Network pharmacology; hawthorn; hyperlipidemia; gene expression omnibus database; UPDATE; IDENTIFICATION; INFLAMMATION; CYTOSCAPE;
D O I
10.36468/pharmaceutical-sciences.spl.655
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A common clinical treatment for hyperlipidemia in China is hawthorn, a traditional Chinese herb. However, few researches have been done on its active ingredients and their possible mechanisms for treating hyperlipidemia. The active chemical constituents of hawthorn were obtained from the encyclopedia of traditional Chinese medicine, the bioavailability and druglikeness properties of each active ingredient of hawthorn were analyzed using SwissADME and their possible targets of action were predicted using SwissTargetPrediction and PharmMapper. Then, we used the Gene Expression Omnibus-related gene microarray data to mine the differentially expressed genes for hyperlipidemia. Meanwhile, we collected relevant targets of hyperlipidemia through the DrugBank, Online Mendelian Inheritance in Man, GeneCards, DisGeNET and Therapeutic Target Database. Based on this data, a component-target-disease pathway and a protein-protein interaction networks were constructed using search tool for the retrieval of interacting genes/proteins. Finally, Metascape was systematically used to analyze the targets of hawthorn intervention in hyperlipidemia. A total of 8 active components and 312 hawthorn targets were gathered and 343 prospective targets associated with hyperlipidemia were predicted, 25 of which shared targets with hawthorn-related targets. Gene ontology enrichment analysis revealed that the mechanism of action of hawthorn in intervention of hyperlipidemia lies in the regulation of lipid metabolism, nutrition level, hormone level and cholesterol transport process. The Kyoto encyclopedia of genes and genomes enrichment analysis revealed that the peroxisome proliferator activated receptor signaling pathway contained the majority of the core targets. Molecular docking verified that hawthorn could bind closely to the core targets. According to the findings of network pharmacology and enrichment analysis, we predicted that the main active components of hawthorn to intervene in hyperlipidemia are epicatechin, officinalic acid and quercetin, which mainly intervene in hyperlipidemia through the peroxisome proliferator activated receptor signaling pathway.
引用
收藏
页码:146 / 158
页数:13
相关论文
共 50 条
  • [1] Curcumin in the Treatment of Periodontitis based on Gene Expression Omnibus Data Mining and Network Pharmacology
    Long, Hailun
    Chen, Xiaotao
    Nan, Xiaomei
    Zheng, Hongyan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 253 - 261
  • [2] Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia
    Xiao, Ping-ting
    Liu, Shi-yu
    Kuang, Yu-jia
    Jiang, Zheng-meng
    Lin, Yang
    Xie, Zhi-shen
    Liu, E-Hu
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 264
  • [3] Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia
    Zhou, Xiaowen
    Yan, Zhenqian
    Wang, Yaxin
    Ren, Qi
    Liu, Xiaoqi
    Fang, Ge
    Wang, Bin
    Li, Xiantao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [4] Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
    Guanlin Xiao
    Zhihao Zeng
    Jieyi Jiang
    Aili Xu
    Sumei Li
    Yangxue Li
    Zhao Chen
    Weitao Chen
    Jingnian Zhang
    Xiaoli Bi
    Scientific Reports, 12
  • [5] Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
    Xiao, Guanlin
    Zeng, Zhihao
    Jiang, Jieyi
    Xu, Aili
    Li, Sumei
    Li, Yangxue
    Chen, Zhao
    Chen, Weitao
    Zhang, Jingnian
    Bi, Xiaoli
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Study based on metabolomics and network pharmacology to explore the mechanism of Ginseng-Douch compound fermentation products in the treatment of hyperlipidemia
    Sun, Jianfeng
    Dong, Wenting
    Zhao, Yuanyuan
    Sun, Guodong
    Chen, Liyan
    Huo, Jinhai
    Wang, Weiming
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2025, 105 (01) : 611 - 625
  • [7] Using Network Pharmacology and Molecular Docking to Explore the Mechanism by Which Dracocephalum rupestre Hance Tea Intervenes in Hyperlipidemia
    Wang T.
    Duan R.
    Yang J.
    Huo M.
    Shipin Kexue/Food Science, 2023, 44 (09): : 7 - 14
  • [8] The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation
    Li, Lin-Zi
    Wang, Hui-Ying
    Huang, Jia-Hui
    Liu, Kun
    Feng, Xiao-Jie
    Wang, Xi-Ming
    Zhu, Li-Jie
    He, Xing-Lishang
    Zheng, Xiang
    Li, Hai-Long
    Dong, Ying-Jie
    Li, Bo
    Wu, Han-Song
    Jiang, Ning-Hua
    Lv, Gui-Yuan
    Chen, Su-Hong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [9] Mechanism of Epigallocatechin-3-gallate in the prevention and treatment of irritable bowel syndrome: A network pharmacology and gene expression omnibus chip data-based study
    Ye, Fangchen
    Li, Laifu
    Wang, Lianli
    Ran, Yan
    Mei, Lin
    Sun, Yating
    Zhang, Xinping
    Dai, Fei
    PHARMANUTRITION, 2025, 31
  • [10] To Explore the Mechanism and Experimental Verification of Brucine Inhibition of Glioblastoma Based on Network Pharmacology
    Xu, Shaoyan
    Jiang, Hairong
    Zhang, Peng
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (06)